Antifungal properties and target evaluation of three putative bacterial histidine kinase inhibitors

被引:25
作者
Deschenes, RJ [1 ]
Lin, H
Ault, AD
Fassler, JS
机构
[1] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA
[2] Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA
关键词
D O I
10.1128/AAC.43.7.1700
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Histidine protein kinases have been explored as potential antibacterial drug targets. The recent identification of two-component histidine kinases in fungi has led us to investigate the antifungal properties of three bacterial histidine kinase inhibitors (RWJ-49815, RWJ-49968, and RWJ-61907). NI three compounds were found to inhibit growth of the Saccharomyces cerevisiae and Candida albicans strains, with MICs ranging from 1 to 20 mu g/ml. However, deletion of SLN1, the only histidine kinase in S. cerevisiae, did not alter drug efficacy. In vitro kinase assays were performed by using the Sln1 histidine kinase purified from bacteria as a fusion protein to glutathione S-transferase. RWJ-49815 and RWJ-49968 inhibited kinase a 50% inhibitory concentration of 10 mu M, whereas RWJ-61907 failed to inhibit at concentrations up to 100 mu M. Based on these results, we conclude that these compounds have antifungal properties; however, their mode of action appears to be independent of histidine kinase inhibition.
引用
收藏
页码:1700 / 1703
页数:4
相关论文
共 26 条
[1]   COS1, a two-component histidine kinase that is involved in hyphal development in the opportunistic pathogen Candida albicans [J].
Alex, LA ;
Korch, C ;
Selitrennikoff, CP ;
Simon, MI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (12) :7069-7073
[2]   Hyphal development in Neurospora crassa: Involvement of a two-component histidine kinase [J].
Alex, LA ;
Borkovich, KA ;
Simon, MI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (08) :3416-3421
[3]  
Ausubel FM, 1995, CURRENT PROTOCOLS MO
[4]   Two-component signal transduction as a target for microbial anti-infective therapy [J].
Barrett, JF ;
Hoch, JA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (07) :1529-1536
[5]   Antibacterial agents that inhibit two-component signal transduction systems [J].
Barrett, JF ;
Goldschmidt, RM ;
Lawrence, LE ;
Foleno, B ;
Chen, R ;
Demers, JP ;
Johnson, S ;
Kanojia, R ;
Fernandez, J ;
Bernstein, J ;
Licata, L ;
Donetz, A ;
Huang, S ;
Hlasta, DJ ;
Macielag, MJ ;
Ohemeng, K ;
Frechette, R ;
Frosco, MB ;
Klaubert, DH ;
Whiteley, JM ;
Wang, L ;
Hoch, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (09) :5317-5322
[6]  
Fabret C, 1998, J BACTERIOL, V180, P6375
[7]  
FONZI WA, 1993, GENETICS, V134, P717
[8]   Antifungal agents: Chemotherapeutic targets and immunologic strategies [J].
Georgopapadakou, NH ;
Walsh, TJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (02) :279-291
[9]  
GOLDSCHMIDT R, COMMUNICATION
[10]   Emerging targets for the development of novel antifungal therapeutics [J].
Groll, AH ;
De Lucca, AJ ;
Walsh, TJ .
TRENDS IN MICROBIOLOGY, 1998, 6 (03) :117-124